Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XRR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,642
Award facts
- Contract value 100% obligated
- $4,642.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,642.20 by the Defense Logistics Agency's Medical Supply Chain for the supply of Xolair 150 mg/ml syringes. The award, issued on August 29, 2025, with an ultimate completion date of September 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military health facilities worldwide.
As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established position to deliver prescription medications, biologics, and specialized pharmaceutical products directly to Department of Defense healthcare sites. Xolair (omalizumab) is a biologic medication used to treat moderate-to-severe allergic asthma and other allergic conditions, making this delivery order consistent with the contractor's portfolio of specialty pharmaceutical products that support military medical readiness and patient care requirements across the defense healthcare system.
Quick answers
Who was awarded contract SPE2DX25F6XRR?
SPE2DX25F6XRR was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 29, 2025.
How much is contract SPE2DX25F6XRR worth?
The government has obligated $4,642 on SPE2DX25F6XRR.
Is contract SPE2DX25F6XRR an order under another contract?
Yes. SPE2DX25F6XRR is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRR competed?
The extent of competition for SPE2DX25F6XRR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award